References
- Kaczorowski E. Exploring statins: What does the evidence say? Women's Health Activist. 2007; May/June. www.nwhn.org/wha_mayjune07_statins.
- Boston Women's Health Book Collective. Our bodies ourselves: Menopause. Boston: Simon & Schuster; 2006. p 253.
- Napoli M. Centre for Medical Consumers, 2007. www.medicalconsumers.org.
- Rosenberg H, Allard D. Evidence for caution: Women and statin use. Women and Health Protection, 2007. www.whp-apsf.ca/pdf/statinsEvidenceCaution.pdf.
- Krieger N, Lowy I, Aronowitz R, Bigby J, Dickersin K, Garner E, et al. Hormone replacement therapy, cancer controversies and women's health: Historical epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health. 2005; 59: 740–8
- Albert CM, Chae CA, Grodstein F, Rose LM, Rexrode KM, Rushkin JN, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003; 107: 2096–101
- Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, Liu K, et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-casue mortality. JAMA. 2004; 292: 1588–92
- Walsh JME, Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 2004; 291: 2243–52
- Therapeutics Initiative. Do statins have a role in primary prevention? Therapeutics Letter 48. 2003. www.ti.ubc.ca/en/node/52.
- Abramson J. Overdosed America: The broken promise of American medicine. HarperCollins, New York 2004
- Hayward RA, Hofer TP, Vijan S. Narrative review: Lack of evidence for recommended low-density lipoprotein treatment targets: A solvable problem. Ann Intern Med. 2006; 145: 520–30
- Abramson J, Wright JM. Are lipid-lowering guidelines evidence-based?. Lancet. 2007; 369: 168–9
- Armitage J. Review: The safety of statins in clinical practice. Lancet. 2007; 370: 1781–90
- Dirks A, Jones KM. Mitochondrial modeling and function: Statin-induced apoptosis and skeletal myopathy. Am J Physiol. 2006; 291: C1208–12
- Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: Implications for patient-targeted adverse effect surveillance. Drug Saf. 2007; 30: 669–75
- Beck P, Wysowski D, Downey W, Butler-Jones D. Statin use and the risk of breast cancer. J Clin Epidemiol. 2003; 56: 280–5
- Edison RJ, Muenke M. Mechanistic and epidemiological considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet. 2004; 131A: 287–98
- Canadian Institutes for Health Research. Gender and sex-based analysis in health research: A guide for CIHR peer review committees, 2006.
- Grady D, Chaput L, Kristof M. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. AHRQ. US Department of Health and Human Services. May 2003. www.ahrq.gov Publication no. 03-Eo35.